Scapa Group PLC Heejae Chae to step down as Group CEO of Scapa (6224Z)
21 Maggio 2019 - 8:02AM
UK Regulatory
TIDMSCPA
RNS Number : 6224Z
Scapa Group PLC
21 May 2019
21 May 2019
LEI No. 213800QIPVTK5ES5UU36
Scapa Group plc
('Scapa' or 'the Company')
Heejae Chae intends to step down as Group Chief Executive of
Scapa Group
Scapa Group plc (AIM: SCPA), a diversified Healthcare and
Industrial company focused on bringing best-in-class innovation,
design and manufacturing solutions to its customers, announces that
after ten years with the Company, Heejae Chae has informed the
Board of his intention to step down as Group Chief Executive and
member of the Board. A search and selection process is underway and
Heejae will remain with the Company to ensure a smooth transition
to a new Group Chief Executive.
Larry Pentz, Chairman of Scapa, commented:
"On behalf of the Board, I would like to thank Heejae for his
excellent leadership and impressive contributions to Scapa since
joining as Group Chief Executive in 2009. During his ten-year
tenure, Heejae has delivered significant growth, greatly improved
efficiency and built firm foundations, setting a strategic
blueprint that will continue to drive future growth. Under his
leadership, the business transformed financially and strategically.
Scapa is a high performing global organisation underpinned by an
entrepreneurial culture which has delivered significant shareholder
value. As a result, Scapa is financially stronger with a successful
strategy and is well placed to deliver on its many future growth
opportunities. We wish Heejae well, when he eventually leaves us
after working through a smooth transition with his successor."
Heejae Chae, Group Chief Executive of Scapa, added:
"It was a difficult decision to step away from my post as Group
Chief Executive of Scapa, but I feel now is the right time to bring
in new leadership to deliver the next phase of our growth strategy.
I have been with the Company through many chapters of its growth,
from a predominantly industrial business to a significant sized
international company now predominantly healthcare focused. I
consider myself privileged to have worked with such esteemed
colleagues and partners during my tenure. I remain committed to
Scapa during this transition period and am confident that the
business is poised to continue to deliver long-term sustainable
growth from the current strategy."
For further information:
Scapa Group plc: +44 (0) 161 301 7400
Wendy Baker
Group General Counsel and Company Secretary
Numis Securities Limited (Nominated Adviser
and Joint Broker) +44 (0) 20 7260 1000
Mark Lander
Richard Thomas
Berenberg (Joint Broker) +44 (0) 20 3207 7800
Chris Bowman
Toby Flaux
FTI Consulting (Media Relations): +44 (0) 20 3727 1000
Brett Pollard
Victoria Foster Mitchell
About Scapa Group plc
Scapa Group plc is a diversified Healthcare and Industrial
company focused on bringing best-in-class innovation, design and
manufacturing solutions to its customers.
Healthcare
Scapa Healthcare is the trusted strategic partner of choice for
the world's leading companies in Advanced Wound Care, Consumer
Wellness and Medical Device Fixation. We partner with the top
global MedTech companies to develop and manufacture innovative skin
friendly medical device fixation and topical solutions, from
inception through to market delivery, from our state-of-the-art
facilities.
For further information, please visit
www.scapahealthcare.com
Industrial
Scapa Industrial is a global supplier of bonding solutions and
manufacturer of adhesive-based products which offer meaningful
value in industrial applications due to their lightweight,
easy-to-apply properties. We are recognised for our unparalleled
range of products, including adhesive tapes, films and foams, and
we can engineer custom designs for even the most unique
applications.
For further information, please visit
www.scapaindustrial.com
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
BOAURAWRKUAVUAR
(END) Dow Jones Newswires
May 21, 2019 02:02 ET (06:02 GMT)
Grafico Azioni Scapa (LSE:SCPA)
Storico
Da Mar 2024 a Apr 2024
Grafico Azioni Scapa (LSE:SCPA)
Storico
Da Apr 2023 a Apr 2024